RU94030499A - Тетрагидроизохинолиновые соединения, их о-ацилированные производные, способ получения, фармацевтическая композиция, способ лечения - Google Patents
Тетрагидроизохинолиновые соединения, их о-ацилированные производные, способ получения, фармацевтическая композиция, способ леченияInfo
- Publication number
- RU94030499A RU94030499A RU94030499/04A RU94030499A RU94030499A RU 94030499 A RU94030499 A RU 94030499A RU 94030499/04 A RU94030499/04 A RU 94030499/04A RU 94030499 A RU94030499 A RU 94030499A RU 94030499 A RU94030499 A RU 94030499A
- Authority
- RU
- Russia
- Prior art keywords
- alkoxy
- alkyl
- phenyl
- substituted
- hydroxy
- Prior art date
Links
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims abstract 11
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract 8
- 150000002367 halogens Chemical class 0.000 claims abstract 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 8
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims abstract 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 3
- 208000018737 Parkinson disease Diseases 0.000 claims abstract 2
- 208000028017 Psychotic disease Diseases 0.000 claims abstract 2
- 125000003118 aryl group Chemical group 0.000 claims abstract 2
- 150000002148 esters Chemical class 0.000 claims abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 201000000980 schizophrenia Diseases 0.000 claims abstract 2
- 125000001424 substituent group Chemical group 0.000 claims abstract 2
- 208000011580 syndromic disease Diseases 0.000 claims abstract 2
- 230000001771 impaired effect Effects 0.000 claims 2
- 125000006684 polyhaloalkyl group Polymers 0.000 claims 2
- 208000012661 Dyskinesia Diseases 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 230000036592 analgesia Effects 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 230000003930 cognitive ability Effects 0.000 claims 1
- 230000006735 deficit Effects 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Тетрагидроизохинолиновые соединения формулы Iи их фармацевтически приемлемые соли, в которых: Rпредставляет один или более заместителей, которые выбирают из Н, галогена, гидрокси, алкила (не обязательно замещенных гидрокси), алкокси, алкилтио, алкилсульфинила, алкилсульфонила, нитро, циана, полигалоалкила, полигалоалкокси, фенила (не обязательно замещенных одним или более галогеном, алкилом или алкокси), или Rявляется карбонилом, не обязательно замещенным карбомоилом; Rпредставляет алифатическую группу, не обязательно замещенную гидрокси или алкокси; Е представляет алкиленовую цепь, не обязательно замещенную одной или более алкильными группами; G представляет фенил или фенил, замещенный одним или более алкил, алкокси, галоген, гидрокси, полигалоалкилом, полигалоалкокси цианом, алкилтио, алкилсульфинилом, алкилсульфонилом, фенилом (не обязательно замещенные одним или более галогеном, алкилом или алкокси), нe обязательно алкилированный карбомоил или G представляет фенильное кольцо, имеющее конденсированное с ним гетероциклическое или ароматическое кольцо; 0 - ацилированные производные, представляющие лиофильные эфиры, которые применяют в анальгезии и при лечении психозов (например, шизофрении), болезни Паркинсона, синдрома Леш-Ньяна, нарушении дефицита внимания или ослабленной познавательной способности, или при облегчении лекарственной зависимости, или замедленной дискинезии.
Claims (1)
- Тетрагидроизохинолиновые соединения формулы I
и их фармацевтически приемлемые соли, в которых: R1 представляет один или более заместителей, которые выбирают из Н, галогена, гидрокси, алкила (не обязательно замещенных гидрокси), алкокси, алкилтио, алкилсульфинила, алкилсульфонила, нитро, циана, полигалоалкила, полигалоалкокси, фенила (не обязательно замещенных одним или более галогеном, алкилом или алкокси), или R1 является карбонилом, не обязательно замещенным карбомоилом; R2 представляет алифатическую группу, не обязательно замещенную гидрокси или алкокси; Е представляет алкиленовую цепь, не обязательно замещенную одной или более алкильными группами; G представляет фенил или фенил, замещенный одним или более алкил, алкокси, галоген, гидрокси, полигалоалкилом, полигалоалкокси цианом, алкилтио, алкилсульфинилом, алкилсульфонилом, фенилом (не обязательно замещенные одним или более галогеном, алкилом или алкокси), нe обязательно алкилированный карбомоил или G представляет фенильное кольцо, имеющее конденсированное с ним гетероциклическое или ароматическое кольцо; 0 - ацилированные производные, представляющие лиофильные эфиры, которые применяют в анальгезии и при лечении психозов (например, шизофрении), болезни Паркинсона, синдрома Леш-Ньяна, нарушении дефицита внимания или ослабленной познавательной способности, или при облегчении лекарственной зависимости, или замедленной дискинезии.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9127306.0 | 1991-12-23 | ||
GB919127306A GB9127306D0 (en) | 1991-12-23 | 1991-12-23 | Therapeutic agents |
CN93109559A CN1045291C (zh) | 1991-12-23 | 1993-06-26 | 制备被取代的四氢异喹啉化合物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94030499A true RU94030499A (ru) | 1996-04-20 |
RU2122999C1 RU2122999C1 (ru) | 1998-12-10 |
Family
ID=36822306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94030499A RU2122999C1 (ru) | 1991-12-23 | 1992-12-12 | Тетрагидроизохинолиновые соединения или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и способ связывания допаминовых рецепторов |
Country Status (28)
Country | Link |
---|---|
US (1) | US5519034A (ru) |
EP (1) | EP0618900B1 (ru) |
JP (1) | JP2642244B2 (ru) |
CN (1) | CN1045291C (ru) |
AT (1) | ATE150015T1 (ru) |
AU (1) | AU662584B2 (ru) |
BG (1) | BG62326B1 (ru) |
CA (1) | CA2126308A1 (ru) |
CZ (1) | CZ282869B6 (ru) |
DE (1) | DE69218248T2 (ru) |
DK (1) | DK0618900T3 (ru) |
ES (1) | ES2098721T3 (ru) |
FI (1) | FI105401B (ru) |
GB (1) | GB9127306D0 (ru) |
GR (1) | GR3023568T3 (ru) |
HR (1) | HRP921458B1 (ru) |
HU (2) | HUT70495A (ru) |
IL (1) | IL104170A (ru) |
IN (1) | IN174437B (ru) |
MX (1) | MX9207495A (ru) |
NO (1) | NO301474B1 (ru) |
NZ (1) | NZ246155A (ru) |
PL (1) | PL173944B1 (ru) |
RO (1) | RO114790B1 (ru) |
RU (1) | RU2122999C1 (ru) |
SI (1) | SI9200410B (ru) |
SK (1) | SK280318B6 (ru) |
WO (1) | WO1993013073A1 (ru) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ290661B6 (cs) * | 1993-06-22 | 2002-09-11 | Knoll Aktiengesellschaft | Tetrahydroisochinolinová sloučenina, způsob její přípravy, farmaceutický prostředek s jejím obsahem a použití |
US5389638A (en) * | 1993-09-10 | 1995-02-14 | Abbott Laboratories | Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors |
MX9709914A (es) * | 1995-06-07 | 1998-03-31 | Pfizer | Derivados de acido bifenil-2-carboxilico-tetrahidro-isoquinolin-6-ilo, su preparacion y el uso de los mismos. |
GB9524681D0 (en) * | 1995-12-02 | 1996-01-31 | Knoll Ag | Chemical process |
JP2000507569A (ja) * | 1996-03-29 | 2000-06-20 | 日本ワイスレダリー株式会社 | 抗精神病薬ならびに鎮痛薬を製造するための、1,1―ジアルキル―1,2,3,4―テトラヒドロイソキノリンの使用 |
EP1023269A4 (en) * | 1997-09-30 | 2001-06-27 | Molecular Design Int | BETA3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USE |
US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
US5919794A (en) * | 1998-05-11 | 1999-07-06 | Virginia Commonwealth University | Methods of using pharmaceutical tetrahydroisoquinolines |
GB0012214D0 (en) * | 2000-05-19 | 2000-07-12 | Merck Sharp & Dohme | Therapeutic agents |
DE10041479A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
US6593341B2 (en) | 2001-03-29 | 2003-07-15 | Molecular Design International, Inc. | β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same |
WO2003007959A1 (en) * | 2001-07-16 | 2003-01-30 | Fujisawa Pharmaceutical Co., Ltd. | Quinoxaline derivatives which have parp inhibitory action |
US6596734B1 (en) | 2002-10-11 | 2003-07-22 | Molecular Design International, Inc. | Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists |
ES2239196T3 (es) * | 2002-12-02 | 2005-09-16 | Schwarz Pharma Ag | Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson. |
ATE450513T1 (de) * | 2004-11-04 | 2009-12-15 | Mallinckrodt Inc | Opiatzwischenprodukte und syntheseverfahren |
US7511060B2 (en) | 2005-10-21 | 2009-03-31 | Mallinckrodt Inc. | Opiate intermediates and methods of synthesis |
US7622586B2 (en) * | 2005-10-21 | 2009-11-24 | Mallinckrodt Inc. | Opiate intermediates and methods of synthesis |
CN102083797B (zh) * | 2008-04-01 | 2014-06-04 | Abbvie公司 | 四氢异喹啉、含有它们的药物组合物和它们在治疗中的用途 |
US20090312558A1 (en) * | 2008-06-13 | 2009-12-17 | Reliance Life Sciences Pvt. Ltd. | Process for the preparation of arylcyclopropoane carboxylic carbonitriles, and compounds derived therefrom |
AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
JP2014521682A (ja) | 2011-08-05 | 2014-08-28 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノクロマン、アミノチオクロマンおよびアミノ−1,2,3,4−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用 |
WO2013072520A1 (en) | 2011-11-18 | 2013-05-23 | AbbVie Deutschland GmbH & Co. KG | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
LT2872145T (lt) | 2012-07-12 | 2022-06-27 | Emalex Biosciences, Inc. | Sujungti benzazepinai tureto sindromui gydyti |
US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
KR101802048B1 (ko) * | 2013-04-02 | 2017-12-28 | 안지 파마슈티컬 코퍼레이션 리미티드 | 항신경퇴행성제로서의 다작용성 퀴놀린 유도체 |
CN103435545B (zh) * | 2013-08-14 | 2015-10-07 | 中国药科大学 | 四氢异喹啉季铵盐类衍生物、其制备方法及其镇痛用途 |
EP3057958B1 (en) | 2013-10-17 | 2019-05-01 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
CA2924689A1 (en) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
PL3057595T3 (pl) | 2013-10-18 | 2021-03-08 | Emalex Biosciences, Inc. | Skondensowane benzazepiny do leczenia jąkania |
WO2019099294A1 (en) | 2017-11-14 | 2019-05-23 | Merck Sharp & Dohme Corp. | Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
AR113878A1 (es) | 2017-11-14 | 2020-06-24 | Merck Sharp & Dohme | Compuestos de biarilo sustituido como inhibidores de indolamina 2,3-dioxigenasa (ido) |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR868733A (fr) * | 1939-10-14 | 1942-01-14 | Troponwerke Dinklage & Co | Procédé pour la fabrication des composés d'isoquinoleine |
US3717639A (en) * | 1967-05-04 | 1973-02-20 | Little Inc A | Process for the preparation of 1-(2-nitro-3,4-di-lower-alkoxybenzyl)isoquinolines |
US3755330A (en) * | 1967-08-25 | 1973-08-28 | Sandoz Ag | 1-{60 -hydroxybenzyl 3-methyl, 1,2,3,4-tetrahydroiso quinolino-2-carbonitriles |
JPS4933805B1 (ru) * | 1969-01-31 | 1974-09-10 | ||
US3852448A (en) * | 1971-02-04 | 1974-12-03 | Sandoz Ag | N-substituted amino-n-nitroso-aminoacetonitriles for treating hypertension |
US3872130A (en) * | 1971-09-27 | 1975-03-18 | Mead Johnson & Co | 1-hydroxyisoquinolones |
US3777026A (en) * | 1972-06-14 | 1973-12-04 | Sandoz Ag | N-substituted amino-n-nitroso-amino-acetonitriles as anti-anginal agents |
US4013664A (en) * | 1973-06-20 | 1977-03-22 | Research Corporation | Synthesis of hernandaline |
US4018927A (en) * | 1973-12-17 | 1977-04-19 | The Regents Of The University Of Michigan | Treatment of proliferating skin diseases with papaverine alkaloids |
US4126615A (en) * | 1975-12-12 | 1978-11-21 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt | Process for the manufacture of pure isoquinoline derivatives |
US4194044A (en) * | 1976-12-06 | 1980-03-18 | Hoffmann-La Roche Inc. | Process for preparing 3-phenoxy morphinans |
US4115389A (en) * | 1977-05-02 | 1978-09-19 | Bristol-Myers Company | Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline |
US4235906A (en) * | 1978-07-21 | 1980-11-25 | Massachusetts General Hospital | Bis-isoquinolinium compounds, compositions and methods of use |
US4491665A (en) * | 1979-10-19 | 1985-01-01 | Burroughs Wellcome Co. | Method of preparing isomers of bis isoquinolinium compounds |
US4514569A (en) * | 1982-01-28 | 1985-04-30 | Hendrickson James B | Synthesis of 1-substituted isoquinolines |
DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
GB8501192D0 (en) * | 1985-01-17 | 1985-02-20 | Boots Co Plc | Therapeutic agents |
DK8386A (da) * | 1986-01-15 | 1987-07-09 | Tpo Pharmachim | Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme |
US4737504A (en) * | 1986-07-25 | 1988-04-12 | Ohio State University Research Foundation | 5-fluoro-and 8-fluoro-trimetoquinol compounds and the processes for their preparation |
US4915879A (en) * | 1986-09-19 | 1990-04-10 | Automatic Liquid Packaging, Inc. | Signal coupling for humidifier container |
GB8921304D0 (en) * | 1989-09-20 | 1989-11-08 | Wyeth John & Brother Ltd | New method of treatment and heterocyclic compounds used therein |
-
1991
- 1991-12-23 GB GB919127306A patent/GB9127306D0/en active Pending
-
1992
- 1992-12-12 ES ES93900051T patent/ES2098721T3/es not_active Expired - Lifetime
- 1992-12-12 AU AU31586/93A patent/AU662584B2/en not_active Ceased
- 1992-12-12 SK SK751-94A patent/SK280318B6/sk unknown
- 1992-12-12 JP JP5511396A patent/JP2642244B2/ja not_active Expired - Lifetime
- 1992-12-12 AT AT93900051T patent/ATE150015T1/de not_active IP Right Cessation
- 1992-12-12 PL PL92304143A patent/PL173944B1/pl unknown
- 1992-12-12 RO RO94-01028A patent/RO114790B1/ro unknown
- 1992-12-12 RU RU94030499A patent/RU2122999C1/ru active
- 1992-12-12 DK DK93900051.9T patent/DK0618900T3/da active
- 1992-12-12 DE DE69218248T patent/DE69218248T2/de not_active Expired - Fee Related
- 1992-12-12 CZ CZ941534A patent/CZ282869B6/cs not_active IP Right Cessation
- 1992-12-12 US US08/244,368 patent/US5519034A/en not_active Expired - Fee Related
- 1992-12-12 WO PCT/EP1992/002900 patent/WO1993013073A1/en active IP Right Grant
- 1992-12-12 CA CA002126308A patent/CA2126308A1/en not_active Abandoned
- 1992-12-12 EP EP93900051A patent/EP0618900B1/en not_active Expired - Lifetime
- 1992-12-12 HU HU9401878A patent/HUT70495A/hu unknown
- 1992-12-12 NZ NZ246155A patent/NZ246155A/en unknown
- 1992-12-17 IN IN757MA1992 patent/IN174437B/en unknown
- 1992-12-18 IL IL10417092A patent/IL104170A/en not_active IP Right Cessation
- 1992-12-22 SI SI9200410A patent/SI9200410B/sl unknown
- 1992-12-22 HR HR9127306.0A patent/HRP921458B1/xx not_active IP Right Cessation
- 1992-12-22 MX MX9207495A patent/MX9207495A/es not_active IP Right Cessation
-
1993
- 1993-06-26 CN CN93109559A patent/CN1045291C/zh not_active Expired - Fee Related
-
1994
- 1994-05-31 BG BG98822A patent/BG62326B1/bg unknown
- 1994-06-22 FI FI943018A patent/FI105401B/fi active
- 1994-06-22 NO NO942375A patent/NO301474B1/no not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00689P patent/HU211302A9/hu unknown
-
1997
- 1997-05-28 GR GR970401221T patent/GR3023568T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94030499A (ru) | Тетрагидроизохинолиновые соединения, их о-ацилированные производные, способ получения, фармацевтическая композиция, способ лечения | |
RU2410378C2 (ru) | Сульфоксиминзамещенные пиримидины в качестве ингибиторов cdk и/или vegf, их получение и применение в качестве лекарственных средств | |
RU2004130488A (ru) | Пиримидиновые производные | |
RU94046169A (ru) | Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ лечения | |
MY118163A (en) | Aryl fused azapolycyclic compounds | |
KR920009815A (ko) | 아미노코우마란 유도체, 그들의 제조방법 및 용도 | |
CY1105035T1 (el) | Συγχωνευμενα με αρυλιο ή ετεροαρυλιο παραγωγα της ιμιδαζολης ως αντιφλεγμονωδεις και αναλγητικοι παραγοντες | |
CA2401229A1 (en) | Aryl fused azapolycyclic compounds | |
KR960700267A (ko) | 피롤리딘 및 티아졸리딘 유도체, 이의 제조 및 이를 함유하는 약제(pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same) | |
ATE253546T1 (de) | Chalcon-derivate und medikamente die diese enthalten | |
KR100565362B1 (ko) | 7-이소인돌린-퀴놀론 카복실산 유도체 및 그 중간체의 제조방법 및 7-이소인돌린-퀴놀론 카복실산 유도체의 염, 그의 수화물 및 이들을 활성성분으로 함유하는 조성물 | |
ES2193151T3 (es) | Enantiomeros de derivados de carbazol como agonistas de tipo 5-ht1. | |
YU64400A (sh) | Aril fuzirana azapoliciklična jedinjenja | |
KR920016424A (ko) | 2-치환 퀴놀린, 이들의 제조 방법 및 의약으로서의 이들의 용도 | |
RU2006117627A (ru) | Новые применения в медицине соединений, обладающих антагонистической активностью по отношению к св1, и комбинированное лечение с применением этих соединений | |
KR940011450A (ko) | 살진균성 2-알콕시-2-이미다졸린-5-온 유도체 | |
KR927003537A (ko) | 4, 5-사이클로알카노-3-벤즈아제핀-7-올 유도체 및 이의 용도 | |
KR930006024A (ko) | 이미다조 인돌리진 유도체 및 그의 제조방법 | |
DE69217613D1 (de) | Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
DE69330601D1 (de) | Serotoninergische ergolin derivate | |
RU94046144A (ru) | Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция | |
FI956150A (fi) | Isokinoliinijohdannaisia terapeuttisina aineina | |
MXPA04003200A (es) | Nuevos compuestos de isoquinolina, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
KR970702272A (ko) | 벤즈옥사제핀 유도체, 이의 염 및 이를 함유하는 약제(Benzoxazepine derivatives, salts thereof, and drugs containing the same) | |
RU2007123252A (ru) | Производные хромана и их применения при лечении заболеваний цнс |